- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04107714
Starting the Conversation (STC)
Starting the Conversation (STC) - Web-based Group Intervention to Support Disclosure Decisions for Parents of Children With Mental Illness
Study Overview
Status
Intervention / Treatment
Detailed Description
Parents of children with mental illness often experience public and self-stigma, and keeping a child's mental illness secret is a common strategy to avoid stigma. Both secrecy and disclosure have pros and cons for parents and their children. Therefore, the decision whether, when, and to whom to disclose a child's mental illness is complex. Interventions can provide guidance for systematic consideration and a well informed decision.
The manualized peer-led group intervention "Honest, Open, Proud" (HOP) supports people with mental illness in their decision whether to disclose mental illness. Research showed positive effects of the intervention on stigma stress, disclosure-related distress and quality of life. Based on HOP, "Starting the Conversation" (STC) was developed to systematically guide parents through their decision whether and how to disclose a child's mental illness.
At the moment, there is no data regarding feasibility and efficacy of STC, but two pilot RCTs of STC are currently underway, one in Western Australia and one in Wisconsin, USA. The aim of the current study is to evaluate feasibility and efficacy of STC as a webinar in a pilot RCT in German.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Ulm, Germany, 89073
- Department of Child and Adolescent Psychiatry, University of Ulm
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parent with at least one child or adolescent that (i) is aged between 6 to 17 years (ii) has a current mental disorder according to ICD-10 diagnosed by a psychiatrist or psychologist
- Age ≥ 18 years
- Positive screening for disclosure distress (1 item: "In general, how distressed or worried are you in terms of secrecy or disclosure of the mental illness of your child?", self-report, persons with a score ≥ 4 on a scale from 1-7 were included)
- Online informed consent
- Sufficient German language skills
Exclusion Criteria:
- Intellectual disability of child (IQ<70, self-report)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention (STC)
Study participants randomized to the experimental group receive the intervention (STC). STC is a peer-led and web-based group intervention containing four two-hour sessions within four weeks plus an additional booster session one month later. Fidelity to manual is rated in each session by study staff. |
The peer-led and web-based group program contains four lessons plus one booster session:
|
|
No Intervention: No intervention
Participants randomized to the control group do not receive the group program but get the accompanying workbook at the end of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-stigma of parents
Time Frame: 8 weeks
|
Parent's Self-Stigma Scale (PSSS) (Eaton et al., 2018), 11 items rated from 1 to 5, sum score (range 5-55) with higher scores indicating more self-stigma.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-stigma of parents
Time Frame: baseline, 4 weeks, 16 weeks
|
Parent's Self-Stigma Scale (PSSS) (Eaton et al., 2018), 11 items rated from 1 to 5, sum score (range 5-55) with higher scores indicating more self-stigma.
|
baseline, 4 weeks, 16 weeks
|
|
Self-stigma of parents
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Self-Stigma in Relatives of People with Mental Illness Scale (SSRMI) (Morris et al., 2018), 10 items rated from 1 to 5, mean score across all items (range 1-5) with higher scores indicating more self-stigma.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Stigma stress related to child's mental illness
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Stigma Stress Scale (Rüsch et al., 2009a,b) adapted for parents of children with mental illness, 8 items rated from 1 to 7 with 4 items measuring the primary appraisal of stigma as harmful and 4 items measuring the secondary appraisal of perceived resources to cope with stigma-related harm, for each of the two subscales there is a mean score (range 1-7), and a total stigma stress score will be calculated by subtracting perceived resources from perceived harm with higher difference scores (range -6 to +6) indicating more stigma stress.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Parenting distress
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Parenting Stress Index, parent domain (PSI) (Tröster, 2011), 28 items rated from 1 to 5, sum scores of subscales (range 4-20) and across all items (range 28-140) with higher scores indicating more parenting distress.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Quality of life of parents
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
World Health Organization Quality of Life Assessment-short form (WHOQOL-BREF), domains general quality of life, psychological and social relationships (Angermeyer, Kilian & Matschinger, 2000), 11 items rated from 1 to 5, mean scores of each domain (range 1-5) with higher scores indicating better quality of life.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Parent-rated child quality of life
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
KIDSCREEN-10, parent version (The KIDSCREEN Group Europe, 2006), 10 items rated from 1 to 5, sum score across all items (range 5-50) with higher scores indicating better child quality of life.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Self-esteem
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Rosenberg Self-Esteem Scale (RSE) (Collani & Herzberg, 2003), 10 items rated from 0 to 3, sum score across all items (range 0-30) with higher scores indicating higher self-esteem.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Social support
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Perceived Social Support Questionnaire (FsozU K-6) (Kliem et al., 2015), 6 items rated from 1 to 5, mean score across all items (range 1-5) with higher scores indicating more perceived social support.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
|
Social inclusion
Time Frame: baseline, 4 weeks, 8 weeks, 16 weeks
|
Social Inclusion Scale (SIS) (Hacking et al., 2008; Secker et al., 2009) adapted for parents of children with mental illness, 20 items rated from 1 to 4, mean scores (range 1-4) of subscales and across all items with higher scores indicating higher social inclusion.
|
baseline, 4 weeks, 8 weeks, 16 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Rusch N, Corrigan PW, Wassel A, Michaels P, Olschewski M, Wilkniss S, Batia K. A stress-coping model of mental illness stigma: I. Predictors of cognitive stress appraisal. Schizophr Res. 2009 May;110(1-3):59-64. doi: 10.1016/j.schres.2009.01.006. Epub 2009 Mar 6.
- Rusch N, Corrigan PW, Powell K, Rajah A, Olschewski M, Wilkniss S, Batia K. A stress-coping model of mental illness stigma: II. Emotional stress responses, coping behavior and outcome. Schizophr Res. 2009 May;110(1-3):65-71. doi: 10.1016/j.schres.2009.01.005. Epub 2009 Feb 23.
- Eaton K, Ohan JL, Stritzke WGK, Corrigan PW. The Parents' Self-Stigma Scale: Development, Factor Analysis, Reliability, and Validity. Child Psychiatry Hum Dev. 2019 Feb;50(1):83-94. doi: 10.1007/s10578-018-0822-8.
- Morris E, Hippman C, Murray G, Michalak EE, Boyd JE, Livingston J, Inglis A, Carrion P, Austin J. Self-Stigma in Relatives of people with Mental Illness scale: development and validation. Br J Psychiatry. 2018 Mar;212(3):169-174. doi: 10.1192/bjp.2017.23. Epub 2018 Feb 5.
- Tröster H. Eltern-Belastungs-Inventar: Deutsche Version des Parenting Stress Index (PSI) von R. R. Abidin [German version of Parenting Stress Index of R. R. Abidin]. Göttingen: Hogrefe; 2011.
- Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: Handbuch für die deutschsprachigen Versionen der WHO Instrumente zur Erfassung von Lebensqualität [WHOQOL-100 and WHOQOL-BREF: Handbook for the German version of WHO instruments to assess quality of life]. Göttingen: Hogrefe; 2000.
- The KIDSCREEN Group Europe. The Kidscreen questionnaires: Quality of life questionnaires for children and adolescents: handbook. Lengerich: Pabst Science Publishers; 2006.
- Kliem S, Mossle T, Rehbein F, Hellmann DF, Zenger M, Brahler E. A brief form of the Perceived Social Support Questionnaire (F-SozU) was developed, validated, and standardized. J Clin Epidemiol. 2015 May;68(5):551-62. doi: 10.1016/j.jclinepi.2014.11.003. Epub 2014 Nov 13.
- Hacking S, Secker J, Spandler H, Kent L, Shenton J. Evaluating the impact of participatory art projects for people with mental health needs. Health Soc Care Community. 2008 Dec;16(6):638-48. doi: 10.1111/j.1365-2524.2008.00789.x. Epub 2008 May 13.
- Secker J, Hacking S, Kent L, Shenton J, Spandler H. Development of a measure of social inclusion for arts and mental health project participants. Journal of Mental Health. 2009;18(1):65-72. doi:10.1080/09638230701677803
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 375/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stigma of Parents of Children With Mental Illness
-
University Medical Center GroningenAccare; Hanzehogeschool Groningen; GGZ Friesland; WIJ Groningen; Amaryllis Leeuwarden and other collaboratorsRecruiting
-
The University of Hong KongCompletedParents of Children With CancerHong Kong
-
The University of Hong KongUnknownParents of Children With CancerHong Kong
-
Chang Gung University of Science and TechnologyChang Gung Memorial HospitalCompletedParents of Children With CancerTaiwan
-
The University of Hong KongCompletedResilience of Parents Having Children With CancerHong Kong
-
Hawler Medical UniversityCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...RecruitingPediatric Cancer | Adolescent Health | Parents of Children With Cancer | Decision Aids | Decision Making ,SharedTaiwan
-
Canterbury Christ Church UniversityUniversity of SurreyCompletedThe Quality of Life of Parents of Children With Food AllergyUnited Kingdom
-
University Hospital, MontpellierCompletedTracheotomised Children | Anxiety of Parents | Depression of ParentsFrance
-
Canterbury Christ Church UniversityBrighton & Sussex Medical SchoolCompletedThe Well Being of Parents of Children With Food AllergiesUnited Kingdom
Clinical Trials on STC
-
STORM Therapeutics LTDCoherus Oncology, Inc.RecruitingSarcoma | Solid Tumor | Leiomyosarcoma | Dedifferentiated LiposarcomaUnited States
-
Groupe Hospitalier de la Rochelle Ré AunisNumaHealth InternationalCompletedCovid19 | SARS-CoV-2 Acute Respiratory DiseaseFrance
-
STORM Therapeutics LTDCompletedCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Brenus PharmaRecruitingUnresectable Metastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal CancerFrance, United States, Belgium
-
Arizona State UniversityNational Institutes of Health (NIH); National Center for Complementary and...Completed
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA)Completed
-
Virginia Commonwealth UniversityAmerican Heart AssociationCompletedHeart FailureUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...GlaxoSmithKline; NovartisCompletedNon-Hodgkin's LymphomaUnited States